Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
Published:
Last Updated:
The short interest data are out for the November 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The November 13 short interest data have been compared with the previous report, and short interest fell in these selected stocks for this settlement date.
Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 7.80 million shares from the previous level of 9.15 million. Shares closed Tuesday at $162.78, in a 52-week trading range of $130.09 to $181.81.
Biogen Inc. (NASDAQ: BIIB) had its short interest fall to 3.04 million shares from the previous 3.38 million. Shares closed Tuesday at $289.15, within a 52-week trading range of $254.00 to $480.18.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 10.52 million shares from the previous 13.44 million. Shares of Celgene closed Tuesday at $112.67, in a 52-week range of $92.98 to $140.72.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest fall to 25.09 million shares from 26.04 million in the previous period. Shares closed Tuesday at $106.57, in a 52-week trading range of $85.95 to $123.37.
MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 120.55 million shares. The previous reading was 120.02 million. The current reading is the one of the highest readings of the year. Shares closed Tuesday at $2.20, in a 52-week trading range of $1.76 to $7.88.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest increased to 6.71 million from the previous level of 6.47 million. The mid-June level was far and away the highest reading on the year, and since that time shares have backed off significantly. Shares closed Tuesday at $177.80, in a 52-week range of $142.02 to $208.88.
ALSO READ: Nasdaq Companies with Largest Short Interest
Essential Tips for Investing (Sponsored)
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
